Fertility and Sterility
Volume 93, Issue 7 , Pages 2182-2188 , 1 May 2010

Does luteal estradiol supplementation have a role in long agonist cycles?

  • Eman A. Elgindy, M.B.B.S.

      Affiliations

    • AlBanoon Fertility Center, Department of Obstetrics & Gynecology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
    • ,
  • Dahlia O. El-Haieg, M.B.B.S., M.D.

      Affiliations

    • AlBanoon Fertility Center, Department of Obstetrics & Gynecology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
    • Corresponding Author InformationReprint requests: Dahila O. El-Haieg, M.B.B.S., M.D., Department of Obstetrics and Gynecology, Zagazig University, Zagazig, Egypt.
    • ,
  • Magdy I. Mostafa, M.B.B.BS., M.D.

      Affiliations

    • Department of Obstetrics & Gynecology, Faculty of Medicine, Cairo University, Cairo, Egypt
    • ,
  • Mostafa Shafiek, M.B.B.S., M.D.

      Affiliations

    • AlBanoon Fertility Center, Department of Obstetrics & Gynecology, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Received 24 July 2008 ,Revised 31 October 2008 ,Accepted 7 January 2009.

References 

  1. Pabuccua R, Akara ME. Luteal phase support in assisted reproductive technology. Curr Opin Obstet Gynecol. 2005;17:277–281
  2. Pritts E, Atwood A. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod. 2002;17:2287–2299
  3. Smitz J, Bourgain C, Van Waesberghe L, Camus M, Devroey P, Van Steirteghem AC. A prospective randomized study on E2 valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. Hum Reprod. 1993;8:40–45
  4. Lewin A, Benshushan A, Mezker E, Yanai N, Schenker JG, Goshen R. The role of estrogen support during the luteal phase of in vitro fertilization–embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone support. Fertil Steril. 1994;62:121–125
  5. Farhi J, Weissman A, Steinfeld Z, Shorer M, Nahum H, Levran D. Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization–embryo transfer cycles. Fertil Steril. 2000;73:761–766
  6. Shetty G, Krishnamurthy H, Krishnamurthy HN, Bhatnagar S, Moudgal RN. Effect of estrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Mol Biol. 1997;61:157–166
  7. Sharara FI, McClamrock HD. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in vitro fertilization outcome. Hum Reprod. 1999;14:2777–2782
  8. Kolibianakis EM, Venetis1 CA, Papanikolaou EG, Diedrich K, Tarlatzis BC, Griesinger G. Estrogen addition to progesterone for luteal phase support incycles stimulated with GnRH analogues and gonadotrophinsfor IVF: a systematic review and meta-analysis. Hum Reprod. 2008;23:1346–1354
  9. Engmann L, Diluigi A, Schmidt D, Benadiva C, Maier D, Nulsen J. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. Fertil Steril. 2008;89:554–561
  10. Fatemi HM, Kolibianakis EM, Camus M, Tournaye H, Donoso P, Papanikolaou E, et al. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Hum Reprod. 2006;21:2628–2632
  11. Ceyhan T, Basaran M, Duru NK, Goktolga U, Yilmaz A, Korkmaz C, et al. Use of luteal estrogen supplementation in normal responder patients treated with fixed multidose GnRH antagonist: a prospective randomized controlled study. Fertil Steril. 2008;89:1827–1830
  12. Serna J, Cholquevique JL, Villasante A, Oriol B, Requena A, Garcia-Velasco J. Adding estradiol patches to the luteal phase of IVI/ICSI cycles did not improve pregnancy nor miscarriage rates. Fertil Steril. 2006;86:S73
  13. Lukaszuk K, Liss J, Lukaszuk M, Maj B. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization–embryo transfer cycles. Fertil Steril. 2005;83:1372–1376
  14. Bulletti C, de Ziegler D, Flamigni C, Giacomucci E, Polli V, Bolelli G, et al. Targeted drug delivery in gynaecology: the first uterine pass effect. Hum Reprod. 1997;12:1073–1079
  15. Van Steirteghem AC, Nagy Z, Joris H, Liu J, Staessen C, Smitz J, et al. High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod. 1993;7:1061–1066
  16. Cicinelli E, De Ziegler D, Morgese S, Bulletti C, Luisi D, Schonauer LM. First uterine pass effect is observed when estradiol is placed in the upper but not lower third of the vagina. Fertil Steril. 2004;81:1414–1416
  17. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotrophins, recombinant luteinizing hormone, or gonadotrophin releasing hormone(GnRH)agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab. 2003;88:4186–4192
  18. Hutchinson-Williams KA, Lunenfeld B, Diamond MP, Lavy G, Boyers SP, DeCherney AH. Human chorionic gonadotrophins, estradiol, and progesterone profiles in conception and nonconception cycles in an in vitro fertilization program. Fertil Steril. 1989;52:441–445
  19. Fatemi HM, Camus M, Kolibianakis EM, Tournaye H, Papanikolaou EG, Donoso P, et al. The luteal phase of recombinant follicle stimulating hormone/gonadotrophin releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. Fertil Steril. 2007;87:504–508
  20. Paria BC, Lim H, Das SK, Reese J, Dey SK. Molecular signaling in uterine receptivity for implantation. Semin Cell Dev Biol. 2000;11:67–76
  21. de Ziegler D, Bouchard P. Understanding endometrial phisiology and menstrual disorders in 1990s. Curr Opin Obstet Gynecol. 1993;5:378–388
  22. De Hertogh R, Vanderheyden I, Glorieux B, Ekka E. Estrogen and progesterone receptors in endometrium and myometrium at the time of blastocyst implantationin in pregnant diabetic rats. Diabetologia. 1989;32:568–572
  23. Fritz MA, Westfahl PK, Graham RL. The effect of luteal phase estrogen antagonist on endometrial development and luteal function in women. J Clin Endocrinol Metab. 1987;65:1006–1013
  24. Goldstein D, Zuckerman H, Harpaz S, Barkai J, Geva A, Gordon S, et al. Correlation between estradiol and progesterone in cycles with luteal phase deficiency. Fertil Steril. 1982;37:348–354
  25. Wright KP, Guibert J, Weitzen S, Davy C, Fauque P, Olivennes F. Artificial versus stimulated cycles of endometrial preparation before frozen-thawed embryo transfer. Reprod Biomed. 2006;13:321–325

 E.A.E. has nothing to disclose. D.O.E-H. has nothing to disclose. M.I.M. has nothing to disclose. M.S. has nothing to disclose.

 This research has been conducted with no special funding.

PII: S0015-0282(09)00115-0

doi: 10.1016/j.fertnstert.2009.01.066

Fertility and Sterility
Volume 93, Issue 7 , Pages 2182-2188 , 1 May 2010

Article Tools

* Image Usage & Resolution